Search Results

1 - 10 of 29 items :

  • "gastrointestinal stromal tumors" x
Clear All
Gastric gastrointestinal stromal tumour

References Miettinen M, Lasota J. Gastrontestinal stromal tumors: review on morphology, molecular pathology and differential diagnosis. Arch Pathol Lab Med 2006; 130 : 1466-78. Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M. Fronm the Archives of the AFIP Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics 2003; 23 : 283-304. Kachanov DY, Dobrenkov KV, Shamanskaya TV, Abdullaev RT, Inushkina EV, Savkova RF, et al. Solid

Open access
Uncommon Finding of a Gastrointestinal Stromal Tumor in a Patient with Hyperechoic Liver Lesions - Case Report

References 1. Liu J, Wang D, Li H, et al - Clinical value of contrast-enhanced ultrasound in diagnosis of hyperechoic liver lesions. Med Sci Monit. 2015; 21:2845 2. Casali PG, Blay JY - ESMO/CONTICANET/EUROBONET Consensus Panel of Experts. Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010; 21:98-102 3. Søreide K, Sandvik OM, Søreide JA, Giljaca V, Jureckova A, Bulusu VR - Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population

Open access
Coexistence of Multiple Gastrointestinal Stromal Tumors and Signet Ring Cell Carcinoma of Stomach in a Patient with Neurofibromatosis Type-1: Case Report / Nörofibromatozis Tip-1’li Hastada Multipl Gastrointestinal Stromal Tümör ve Midede Taşlı Yüzük Hücreli Karsinom Birlikteliği: Olgu Sunumu

. Rev Esp Enferm Dig 2010, 102: 489-497 9. Kinoshita K, Hirota S, Isozaki K, Ohashi A, Nishida T, Kitamura Y, Shinomura Y, Matsuzawa Y: Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. J Pathol 2004, 202: 80-85 10. Yantiss RK, Rosenberg AE, Sarran L, Besmer P, Antonescu CR: Multiple gastrointestinal stromal tumors in type I neurofibromatosis: A pathologic and molecular study. Mod Pathol 2005, 18: 475-484 11. Maruta H, Burgess AW: Regulation of the Ras

Open access
Surgical Risk Factors of Patients with Operable Gist

Surg Oncol 2011, 9:13 8. Unalp HR, Erdinc K HD, AliB, Ercument T, Mehmet O. Gastrointestinal stromal tumours: outcomes of surgical management and analysis of prognostic variables. Can J Surg, 52 9. Pleşea IE, Chiuţu L, Bordu SI, Georgescu I, Georgescu EF, Ciobanu D, Mărgăritescu ND, Comănescu V, Nemeş R. Gastrointestinal stromal tumors- a clinical-morphological study on 15 cases. Rom J Morphol Embryol 2014;55:513-523. 10. Zhen H, Yuan Li, Hong Z, Jian Z, Jian C. Prognostic factors and clinicopathological characteristics of small gastrointestinal

Open access
Synchronous Occurrence of Ileal Stromal Tumor (GIST) and Colonic Adenocarcinoma: A Case Report/ Синхроно Јавување На Илеален Стромален Тумор (Гист) И Аденокарцином На Колон – Приказ На Случај

References 1. Hsiao H. H, Sheau-Fang Yang S. F, Liu Y. C, Yang M. J, Lin S. F. Synchronous gastrointestinal stromal tumor and adenocarcinoma at the gastroesophageal junction. Med Sci. 2009; 25(6): 338-41. 2. Nakamura S, Aoyagi K, Iwanaga S, et al. Synchronous and metachronous primary gastric lymphoma and adenocarcinoma: a clinicopathological study of 12 patients. Cancer. 1997; 79(6): 1077-85. 3. Liu S. W, Chen G. H, Hsieh P. P. Collision tumor of the stomach. J Clin Gastroenterol. 2002; 35(4): 332

Open access
in PRILOZI
Mesenteric fibromatosis with intestinal involvement mimicking a gastrointestinal stromal tumour

, Dileo P, Gill RR, et al. Multimodality treatment of mesenteric desmoid tumours. Eur J Cancer 2008; 44 : 2404-10. Wcislo G, Szarlej-Wcislo K, Szczylik C. Control of aggressive fibromatosis by treatment with imatinib mesylate. A case report and review of the literature. J Cancer Res Clin Oncol 2007; 133 : 533-8. Zokalj I, Culinovic-Caic R, Magas Z, Pavcec Z, Saghir H, Igrec J, et al. Gastric gastrointestinal stromal tumour. Radiol Oncol 2008; 42 : 187-95. Yantiss RK, Spiro IJ, Compton

Open access
Limits of Dideoxysequencing in the Detection of Somatic Mutations in Gastrointestinal Stromal Tumors

REFERENCES 1. Lodish H, Berk A, Matsudaira P et al. Molecular Cell Biology. New York: H. Freeman, 2007. 2. Hostein I, Faur N, Primois C et al. BRAF mutations status in gastrointestinal stromal tumors. Am. J Clin Pathol 2010; 1 (133): 141-148. 3. Su Z, Dias-Santagata D, Duke M et al. A platform for rapid detection of multiple oncogenic mutations with relevance to targeted therapy in non-small-cell lung cancer. J Mol Diagn 2011; 13 (1): 74-84. 4. Rubin BP. Gastrointestinal stromal tumours: an update. Histopathology 2006; 48 (1): 83

Open access
Gastrointestinal Stromal Tümörü Taklit Eden Gossypiboma (Tekstiloma): Olgu Sunumu/ A Gossypiboma (Textiloma) Mimicking a Gastrointestinal Stromal Tumor: A Case Report

;122-4. 4. Yamamura N, Nakajima K, Takahashi T, Uemura M, Nishitani A, Souma Y, Nishida T. Intra-abdominal textiloma. A retained surgical sponge mimicking a gastric gastrointestinal stromal tumor: Report of a case. Surg Today. 2008;38:552-4. 5. Patil KK, Patil SK, Gorad KP, Panchal AH, Arora SS, Gautam RP. Intraluminal migration of surgical sponge: Gossypiboma. Saudi J Gastroenterol. 2010;16:221-2. 6. McIntyre LK, Jurkovich GJ, Gunn ML, Maier RV. Gossypiboma: Tales of lost sponges and lessons learned. Arch Surg. 2010;145: 770-5.

Open access
Extra-Gastrointestinal retroperitoneal giant stromal tumor complicated with intra-tumoral hemorrhage: case report and literature review

References 1. Stamatakos, M., Douzinas, E., Stefanaki, C., Safioleas, P., Polyzou, E., Levidou, G. & Safioleas, M., (2009). Gastrointestinal stromal tumor - Review. World Journal of Surgical Oncology. 7, 61. DOI:10.1186/1477-7819-7-61 2. Joensuu, H. (2006). Gastrointestinal stromal tumor (GIST). Annals of Oncology. 17(10), 280-286 3. Kim, K.M., Kang, D.W., Moon, W.S., Park, J.B., Park, C.K., Sohn, J.H., Jeong, J.S., Cho, M.Y., Jin, S.Y., Choi, J.S. & Kang, D.Y. (2005). Gastrointestinal Stromal Tumor Committee

Open access
Imatinib-induced subclinical liver injury: histological changes of non-tumorous hepatic parenchyma

References 1. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002; 347:472-80. 2. Schwetz BA. New Treatment for Chronic Myelogenous Leukemia. JAMA. 2001; 286:35. 3. Cohen MH, Williams G, Johnson JR, Duan J, Gobburu J, Rahman A, et al. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. Clin Cancer Res. 2002; 8: 935

Open access